News

In The News ADVI’s Dr. Kolodziej, Vice President and Chief Innovation Officer, Recognized for Outstanding Achievements
In The News Rebecca Davison discusses Trump’s 2020 Budget with CNBC
In The News ADVI’s Lindsay Bealor Greenleaf spoke with The Daily Caller about the future for ACA implementation, and how Congress may act to address rising Exchange premiums and deductibles
In The News ADVI Director Lindsay Bealor Greenleaf talks to Bloomberg Law
In The News ADVI director, Becca Davison, spoke with Morning Consult about defining value for pharmaceuticals and which factors are important to include in the process
In The News ADVI Director, Lindsay Bealor Greenleaf, talked with CNBC about the Administration’s proposed rule on rebates and what it could mean for drug prices and PBMs
In The News Director Lindsay Bealor Greenleaf discussed concerns regarding Medicare Part B step therapy with FierceHealthcare
In The News ADVI’s Lindsay Bealor Greenleaf talks to Bloomberg Law about Drug Pricing Reform Expectations Under the 116th Congress
In The News ADVI’s Michael Kolodziej explains that the OCM could stimulate fine-tuned bundled payments and advance cancer care